| 000 | 01280 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513223049.0 | ||
| 264 | 0 | _c20001122 | |
| 008 | 200011s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/S0140-6736(00)02848-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSeidl, R | |
| 245 | 0 | 0 |
_aEffects of transdermal nicotine on cognitive performance in Down's syndrome. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cOct 2000 |
||
| 300 |
_a1409-10 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Letter; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Cutaneous |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCognition _xdrug effects |
| 650 | 0 | 4 |
_aDown Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aElectric Stimulation |
| 650 | 0 | 4 |
_aEvoked Potentials, Auditory _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNicotine _xadministration & dosage |
| 650 | 0 | 4 |
_aNicotinic Agonists _xadministration & dosage |
| 700 | 1 | _aTiefenthaler, M | |
| 700 | 1 | _aHauser, E | |
| 700 | 1 | _aLubec, G | |
| 773 | 0 |
_tLancet (London, England) _gvol. 356 _gno. 9239 _gp. 1409-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(00)02848-8 _zAvailable from publisher's website |
| 999 |
_c10995372 _d10995372 |
||